S S Damodaran, J K Thankamma. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntipsychotic Agents/therapeutic useBasal Ganglia Diseases/chemically inducedBasal Ganglia Diseases/drug therapyBenzodiazepinesFemaleHaloperidol/adverse effectsHaloperidol/therapeutic useHumansMouth Diseases/chemically inducedMouth Diseases/drug therapyOlanzapinePirenzepine/analogs & derivativesPirenzepine/therapeutic useSchizophrenia/drug therapyStereotypic Movement Disorder/chemically inducedStereotypic Movement Disorder/drug therapySyndromeTreatment Outcome
Substances： See more » Antipsychotic AgentsBenzodiazepinesPirenzepineHaloperidolOlanzapine
Year: 2000 PMID： 11185940 DOI： 10.1080/000486700377
Source DB: PubMed Journal: Aust N Z J Psychiatry ISSN： 0004-8674 Impact factor: 5.744